| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.33B | +30.4% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | -0.5% |
| Gross margin | 24.8% | Net margin 8.0% |
| Revenue Q/Q | -4.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.25B | 75.2% |
| R&D | ¥0.02B | 5.0% |
| SG&A | ¥0.03B | 9.5% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
佰奥智能 ・ 浙矿股份 ・ 浙江力诺 ・ 博汇股份 ・ 酷特智能 ・ 康华生物 ・ 帝科股份 ・ 胜蓝股份 ・ 山水比德 ・ 捷安高科 ・ 首都在线 ・ 中船汉光
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies